{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:44:40Z","timestamp":1781649880513,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"grants from the Ministry Science and Technology of China","award":["2016YFC0901200, 2016YFC0901205"],"award-info":[{"award-number":["2016YFC0901200, 2016YFC0901205"]}]},{"name":"research grants from Health and Family Planning Commission of Sichuan Province","award":["16129"],"award-info":[{"award-number":["16129"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Altered circulating levels and genetic variation of B-type natriuretic peptide (BNP), has been associated with lower bone mineral density (BMD) values and incidence of osteoporosis in peritoneal dialysis patients, renal transplant recipients, and postmenopausal women. The potential relationship of circulating BNP with osteoporosis in patients with type 2 diabetes mellitus (T2DM), however, has not yet been studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Circulating BNP levels were measured in 314 patients with T2DM, and participants were divided into normal BMD group (<jats:italic>n<\/jats:italic>\u2009=\u200973), osteopenia group (<jats:italic>n<\/jats:italic>\u2009=\u2009120), and osteoporosis group (<jats:italic>n<\/jats:italic>\u2009=\u2009121). The association of circulating BNP with diabetic osteoporosis and other parameters was analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Circulating BNP was significantly higher in diabetic osteoporosis subjects than normal and osteopenia groups (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01 or <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Circulating BNP levels correlated significantly and positively with neutrophil to lymphocyte ratio, systolic blood pressure, urinary albumin-to-creatinine ratio, and prevalence of hypertension, peripheral arterial disease, diabetic retinopathy, peripheral neuropathy, and nephropathy, and negatively with triglyceride, fasting blood glucose, lymphocyte count, hemoglobin, estimated glomerular filtration rate, bilirubin, osteoporosis self-assessment tool for Asians, BMD at different skeletal sites and corresponding T scores (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01 or <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). After multivariate adjustment, circulating BNP remained independently significantly associated with the presence of osteoporosis (odds ratio, 2.710; 95% confidence interval, 1.690\u20134.344; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). BMD at the femoral neck and total hip and corresponding T scores were progressively decreased, whereas the prevalence of osteoporosis was progressively increased with increasing BNP quartiles (<jats:italic>P<\/jats:italic> for trend&lt;\u20090.01). Moreover, receiver-operating characteristic analysis revealed that the optimal cutoff point of circulating BNP to indicate diabetic osteoporosis was 16.35\u2009pg\/ml.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Circulating BNP level may be associated with the development of osteoporosis, and may be a potential biomarker for diabetic osteoporosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04138-3","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T06:03:09Z","timestamp":1615356189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of circulating B-type natriuretic peptide with osteoporosis in a Chinese type 2 diabetic population"],"prefix":"10.1186","volume":"22","author":[{"given":"Pan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6692-2401","authenticated-orcid":false,"given":"Pijun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"issue":"1","key":"4138_CR1","doi-asserted-by":"publisher","first-page":"dgz036","DOI":"10.1210\/clinem\/dgz036","volume":"105","author":"Y Li","year":"2020","unstructured":"Li Y, Zhao Z, Wang L, Fu Z, Ji L, Wu X. The Prevalence of Osteoporosis Tested by Quantitative Computed Tomography in Patients With Different Glucose Tolerances. J Clin Endocrinol Metab. 2020;105(1):dgz036.","journal-title":"J Clin Endocrinol Metab"},{"key":"4138_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13098-017-0278-1","volume":"9","author":"CP Sanches","year":"2017","unstructured":"Sanches CP, Vianna AGD, Barreto FC. The impact of type 2 diabetes on bone metabolism. Diabetol Metab Syndr. 2017;9:85.","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"4138_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1570161116666171205104851","volume":"16","author":"SA Paschou","year":"2018","unstructured":"Paschou SA, Anagnostis P, Vryonidou A, Goulis DG. Diabetes and atherosclerosis: old players in a new field, Osteoporosis. Curr Vasc Pharmacol. 2018;16(6):524\u20137.","journal-title":"Curr Vasc Pharmacol"},{"key":"4138_CR4","doi-asserted-by":"publisher","first-page":"3876957","DOI":"10.1155\/2019\/3876957","volume":"2019","author":"S Mohsin","year":"2019","unstructured":"Mohsin S, Kaimala S, Sunny JJ, Adeghate E, Brown EM. Type 2 diabetes mellitus increases the risk to hip fracture in postmenopausal osteoporosis by deteriorating the trabecular bone microarchitecture and bone mass. J Diabetes Res. 2019;2019:3876957.","journal-title":"J Diabetes Res"},{"issue":"3","key":"4138_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0168-8227(00)00119-4","volume":"48","author":"K Suzuki","year":"2000","unstructured":"Suzuki K, Sugimoto C, Takizawa M, Ishizuka S, Kikuyama M, Togawa H, et al. Correlations between bone mineral density and circulating bone metabolic markers in diabetic patients. Diabetes Res Clin Pract. 2000;48(3):185\u201391.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"4138_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCHEARTFAILURE.110.957332","volume":"4","author":"T Ueland","year":"2011","unstructured":"Ueland T, Dahl CP, Kjekshus J, Hulthe J, B\u00f6hm M, Mach F, et al. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. Circ Heart Fail. 2011;4(2):145\u201352.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"4138_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044242","volume":"7","author":"YH Chen","year":"2012","unstructured":"Chen YH, Wu YW, Yang WS, Wang SS, Lee CM, Chou NK, et al. Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. PLoS One. 2012;7(8):e44242.","journal-title":"PLoS One"},{"issue":"4","key":"4138_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173799","volume":"12","author":"N Verheyen","year":"2017","unstructured":"Verheyen N, Fahrleitner-Pammer A, Belyavskiy E, Gruebler MR, Dimai HP, Amrein K, et al. Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: the EPATH trial. PLoS One. 2017;12(4):e0173799.","journal-title":"PLoS One"},{"issue":"1","key":"4138_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13075-018-1805-7","volume":"21","author":"Z Szekanecz","year":"2019","unstructured":"Szekanecz Z, Raterman HG, Peth\u0151 Z, Lems WF. Common mechanisms and holistic care in atherosclerosis and osteoporosis. Arthritis Res Ther. 2019;21(1):15.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"4138_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1023\/A:1027343606509","volume":"17","author":"T Shiga","year":"2003","unstructured":"Shiga T, Hosaka F, Wakaumi M, Matsuda N, Tanizaki K, Kajimoto K, et al. Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia. Cardiovasc Drugs Ther. 2003;17(4):325\u201333.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4\u20135","key":"4138_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.clinbiochem.2007.10.005","volume":"41","author":"CM Balion","year":"2008","unstructured":"Balion CM, Santaguida P, McKelvie R, Hill SA, McQueen MJ, Worster A, et al. Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clin Biochem. 2008;41(4\u20135):231\u20139.","journal-title":"Clin Biochem"},{"issue":"1","key":"4138_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1532\/IJH97.A10502","volume":"83","author":"YS Lin","year":"2006","unstructured":"Lin YS, Chu PH, Kuo MC, Jung SM, Lim KE, Kuo CT, et al. Use of a B-type natriuretic peptide in evaluating the treatment response of a relapsed lymphoma with cardiac involvement. Int J Hematol. 2006;83(1):44\u20136.","journal-title":"Int J Hematol"},{"issue":"6","key":"4138_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S1262-3636(07)70232-X","volume":"31","author":"S Beer","year":"2005","unstructured":"Beer S, Golay S, Bardy D, Feihl F, Gaillard RC, Bachmann C, et al. Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications. Diabetes Metab. 2005;31(6):567\u201373.","journal-title":"Diabetes Metab"},{"issue":"8","key":"4138_CR14","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/ijms20081820","volume":"20","author":"Z Cao","year":"2019","unstructured":"Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine. Int J Mol Sci. 2019;20(8):1820.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4138_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1080\/14728222.2016.1254198","volume":"20","author":"C Moro","year":"2016","unstructured":"Moro C. Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity. Expert Opin Ther Targets. 2016;20(12):1445\u201352.","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"4138_CR16","first-page":"68","volume":"28","author":"CH Wang","year":"2016","unstructured":"Wang CH, Tsai JP, Lai YH, Lin YL, Kuo CH, Hsu BG. Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients. Ci Ji Yi Xue Za Zhi. 2016;28(2):68\u201372.","journal-title":"Ci Ji Yi Xue Za Zhi"},{"issue":"10","key":"4138_CR17","first-page":"3443","volume":"46","author":"MC Lee","year":"2014","unstructured":"Lee MC, Lee CJ, Shih MH, Ho GJ, Chen YC, Hsu BG. N-terminal pro-B-type natriuretic peptide is inversely related to bone mineral density in renal transplant recipients. Transplant\u2002Proc. 2014;46(10):3443\u20137.","journal-title":"Transplant\u2002Proc"},{"issue":"5","key":"4138_CR18","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1073\/pnas.95.5.2337","volume":"95","author":"M Suda","year":"1998","unstructured":"Suda M, Ogawa Y, Tanaka K, Tamura N, Yasoda A, Takigawa T, et al. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc NatlAcad Sci U S A. 1998;95(5):2337\u201342.","journal-title":"Proc NatlAcad Sci U S A"},{"key":"4138_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2018.07.033","volume":"486","author":"P Yan","year":"2018","unstructured":"Yan P, Zhang Z, Wan Q, Zhu J, Li H, Gao C, et al. Association of serum uric acid with bone mineral density and clinical fractures in Chinese type 2 diabetes mellitus patients: a cross-sectional study. Clin Chim Acta. 2018;486:76\u201385.","journal-title":"Clin Chim Acta"},{"key":"4138_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13098-019-0498-7","volume":"11","author":"P Yan","year":"2019","unstructured":"Yan P, Zhang Z, Miao Y, Xu Y, Zhu J, Wan Q. Physiological serum total bilirubin concentrations were inversely associatedwith diabetic peripheral neuropathy in Chinese patients with type 2 diabetes: a cross-sectional study. Diabetol Metab Syndr. 2019;11:100.","journal-title":"Diabetol Metab Syndr"},{"issue":"13","key":"4138_CR21","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.3390\/ijerph16132338","volume":"16","author":"P Wang","year":"2019","unstructured":"Wang P, Abdin E, Shafie S, Chong SA, Vaingankar JA, Subramaniam M. Estimation of prevalence of osteoporosis using OSTA and its correlation with Sociodemographic factors, disability and comorbidities. Int J Environ Res Public Health. 2019;16(13):2338.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"4138_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00198-008-0680-5","volume":"20","author":"MM Pinheiro","year":"2009","unstructured":"Pinheiro MM, Ciconelli RM, Martini LA, Ferraz MB. Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian osteoporosis study (BRAZOS). Osteoporos Int. 2009;20(3):399\u2013408.","journal-title":"Osteoporos Int"},{"issue":"5","key":"4138_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/cen.13560","volume":"88","author":"N Huang","year":"2018","unstructured":"Huang N, Zhou J, Wang W, Wang Q, Tang Y, Sun Y, et al. Retinol-binding protein 4 is positively associated with bone mineral density in patients with type 2 diabetes and osteopenia or osteoporosis. Clin Endocrinol. 2018;88(5):659\u201364.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"4138_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s100380300010","volume":"48","author":"M Kajita","year":"2003","unstructured":"Kajita M, Ezura Y, Iwasaki H, Ishida R, Yoshida H, Kodaira M, et al. Association of the -381T\/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss. J Hum Genet. 2003;48(2):77\u201381.","journal-title":"J Hum Genet"},{"issue":"6","key":"4138_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1359\/jbmr.081262","volume":"24","author":"PJ Buizert","year":"2009","unstructured":"Buizert PJ, van Schoor NM, Lips P, Deeg DJ, Eekhoff EM. Lipid levels: a link between cardiovascular disease and osteoporosis? J Bone Miner Res. 2009;24(6):1103\u20139.","journal-title":"J Bone Miner Res"},{"key":"4138_CR26","doi-asserted-by":"publisher","first-page":"12515","DOI":"10.1096\/fj.201802805RR","volume":"33","author":"Y An","year":"2019","unstructured":"An Y, Zhang H, Wang C, Jiao F, Xu H, Wang X, et al. Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 2019;33:12515\u201327.","journal-title":"FASEB J"},{"key":"4138_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijcard.2019.05.002","volume":"290","author":"S Del Turco","year":"2019","unstructured":"Del Turco S, Basta G, De Caterina AR, Sbrana S, Paradossi U, Taddei A, et al. Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneouscoronary intervention (PPCI): its influence on no-reflow and mortality. Int J Cardiol. 2019;290:34\u20139.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4138_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijcard.2007.03.108","volume":"126","author":"A Rudiger","year":"2008","unstructured":"Rudiger A, Fischler M, Harpes P, Gasser S, Hornemann T, von Eckardstein A, et al. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts. Int J Cardiol. 2008;126(1):28\u201331.","journal-title":"Int J Cardiol"},{"issue":"8","key":"4138_CR29","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1097\/01.CCM.0000229144.97624.90","volume":"34","author":"A Rudiger","year":"2006","unstructured":"Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M. Comparable increase of B-type natriuretic peptide and amino-terminal pro- B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006;34(8):2140\u20134.","journal-title":"Crit Care Med"},{"key":"4138_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fendo.2019.00842","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu Y, Vu V, Sweeney G. Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases. Front Endocrinol (Lausanne). 2019;10:842.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"24","key":"4138_CR31","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","volume":"112","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112(24):3738\u201344.","journal-title":"Circulation."},{"issue":"4","key":"4138_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jbspin.2016.09.022","volume":"84","author":"M Laroche","year":"2017","unstructured":"Laroche M, P\u00e9courneau V, Blain H, Breuil V, Chapurlat R, Cortet B, et al. Osteoporosis and ischemic cardiovascular disease. Joint Bone Spine. 2017;84(4):427\u201332.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"4138_CR33","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1530\/EJE-15-0155","volume":"173","author":"J Starup-Linde","year":"2015","unstructured":"Starup-Linde J, Vestergaard P. Management of endocrine disease: diabetes and osteoporosis: cause for concern? Eur J Endocrinol. 2015;173(3):R93\u20139.","journal-title":"Eur J Endocrinol"},{"key":"4138_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2147\/VHRM.S67753","volume":"10","author":"K Hamano","year":"2014","unstructured":"Hamano K, Nakadaira I, Suzuki J, Gonai M. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes. Vasc Health Risk Manag. 2014;10:585\u20139.","journal-title":"Vasc Health Risk Manag"},{"issue":"10","key":"4138_CR35","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1007\/s00125-006-0352-y","volume":"49","author":"H Makino","year":"2006","unstructured":"Makino H, Mukoyama M, Mori K, Suganami T, Kasahara M, Yahata K, et al. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia. 2006;49(10):2514\u201324.","journal-title":"Diabetologia."},{"issue":"8","key":"4138_CR36","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0890","volume":"30","author":"J Jurado","year":"2007","unstructured":"Jurado J, Ybarra J, Ferrandiz M, Comerma L, Pou JM. Amino-terminal brain natriuretic peptide is related to the presence of diabetic polyneuropathy independently of cardiovascular disease. Diabetes Care. 2007;30(8):e86.","journal-title":"Diabetes Care"},{"issue":"6","key":"4138_CR37","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1073\/pnas.0538059100","volume":"100","author":"K Yamahara","year":"2003","unstructured":"Yamahara K, Itoh H, Chun TH, Ogawa Y, Yamashita J, Sawada N, et al. Significance and therapeutic potential of the natriuretic peptides\/cGMP\/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci U S A. 2003;100(6):3404\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4138_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0003319711423095","volume":"63","author":"J Fan","year":"2012","unstructured":"Fan J, Jouni H, Khaleghi M, Bailey KR, Kullo IJ. Serum N-terminal pro-B-type natriuretic peptide levels are associated with functional capacity in patients with peripheral arterial disease. Angiology. 2012;63(6):435\u201342.","journal-title":"Angiology"},{"issue":"8","key":"4138_CR39","first-page":"2202","volume":"37","author":"P Welsh","year":"2014","unstructured":"Welsh P, Woodward M, Hillis GS, Li Q, Marre M, Williams B, et al. Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial. Diabetes\u2002Care. 2014;37(8):2202\u201310.","journal-title":"Diabetes\u2002Care"},{"issue":"11","key":"4138_CR40","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.2337\/dc14-0669","volume":"37","author":"G Gruden","year":"2014","unstructured":"Gruden G, Landi A, Bruno G. Natriuretic peptides, heart, and adipose tissue: new findings and future developments for diabetes research. Diabetes Care. 2014;37(11):2899\u2013908.","journal-title":"Diabetes Care"},{"key":"4138_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1472-6823-14-27","volume":"14","author":"QH Jin","year":"2014","unstructured":"Jin QH, Ye WL, Chen HH, He XJ, Li TL, Liu Q, et al. Levels of brain natriuretic peptide are associated with peripheral arterial disease in subjects with type-2 diabetes mellitus. BMC Endocr Disord. 2014;14:27.","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"4138_CR42","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.amjcard.2009.01.355","volume":"103","author":"SH Sung","year":"2009","unstructured":"Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol. 2009;103(10):1411\u20136.","journal-title":"Am J Cardiol"},{"issue":"10","key":"4138_CR43","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/ajh\/hpv026","volume":"28","author":"JK Bower","year":"2015","unstructured":"Bower JK, Lazo M, Matsushita K, Rubin J, Hoogeveen RC, Ballantyne CM, et al. N-terminal pro-brain natriuretic peptide (NT-proBNP) and risk of hypertension in the atherosclerosis risk in communities (ARIC) study. Am JHypertens. 2015;28(10):1262\u20136.","journal-title":"Am JHypertens"},{"issue":"5","key":"4138_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/HJH.0b013e3282f624a0","volume":"26","author":"R Sarzani","year":"2008","unstructured":"Sarzani R, Salvi F, Dess\u00ec-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26(5):831\u201343.","journal-title":"J Hypertens"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-021-04138-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T07:10:01Z","timestamp":1615360201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04138-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4138"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04138-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"15 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The retrospective study was reviewed and approved by the human research ethics committee of the Affiliated Hospital of Southwest Medical University in accordance with the 1975 Declaration of Helsinki, and verbal informed consents were obtained from all patients to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}